Publications by authors named "Y Kanal"
Percutaneous Coronary Intervention Induced-No-reflow in Saphenous Vein Grafts.
Arq Bras Cardiol
September 2024
Recent randomized clinical trials demonstrated that treatment with sodium-glucose cotransporter-2 inhibitors (SGLT2is) reduces the risk of cardiac mortality due to sudden cardiac death and progressive pump failure in patients with heart failure (HF). Mechanisms underlying the potential anti-arrhythmic effects of SGLT2is are not well understood. We aimed to examine the effect of SGLT2i treatment on the frontal-plane QRS-T (f[QRS-T]) angle, a novel marker of myocardial repolarization and an independent predictor of adverse cardiac outcomes.
View Article and Find Full Text PDFArticle Synopsis
- The study aimed to explore the link between the severity of coronary artery lesions, measured by the SYNTAX score, and post-discharge sleep quality, assessed using the Pittsburgh Sleep Quality Index (PSQI).
- A total of 424 patients with acute coronary syndrome participated, with 69.34% having a SYNTAX score of ≤22 and the rest >22, revealing no significant differences in age or sex distribution between the groups.
- The analysis found that while several factors were linked to poor sleep quality, only a high SYNTAX score (>22) was independently associated with worse sleep quality after discharge.